Urologic Diseases  >>  cyclosporine  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00195468: Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

Completed
4
280
RoW
CYCLOSPORINE
Wyeth is now a wholly owned subsidiary of Pfizer
Kidney Failure, Graft vs Host Disease
11/06
11/06
NCT00160966: Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

Completed
4
108
Europe
Ciclosporin and Mycophenolate-mofetil, Tacrolimus and Mycophenolate-mofetil, Tacrolimus and Mycophenolate-mofetil with change from Mycophenolate-mofetil to Everolimus
University of Giessen, Heidelberg University, Hoffmann-La Roche, Astellas Pharma Inc, Novartis
Polyomavirus Infections
03/10
03/10

Download Options